Am I eligible for this trial based on my current health and treatment history?

This is a question you may want to discuss with your doctor regarding the KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer clinical trial (NCT05985109). Contact the study team or your healthcare provider for specific answers.

How does this combination treatment compare to my current options?

This is a question you may want to discuss with your doctor regarding the KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer clinical trial (NCT05985109). Contact the study team or your healthcare provider for specific answers.

What are the potential side effects I should be aware of?

This is a question you may want to discuss with your doctor regarding the KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer clinical trial (NCT05985109). Contact the study team or your healthcare provider for specific answers.

How often will I need to come in for treatment and monitoring?

This is a question you may want to discuss with your doctor regarding the KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer clinical trial (NCT05985109). Contact the study team or your healthcare provider for specific answers.

What happens if I experience side effects during the trial?

This is a question you may want to discuss with your doctor regarding the KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer clinical trial (NCT05985109). Contact the study team or your healthcare provider for specific answers.

Are there any additional costs or travel requirements for participating in this trial?

This is a question you may want to discuss with your doctor regarding the KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer clinical trial (NCT05985109). Contact the study team or your healthcare provider for specific answers.

Finding studies

Back

KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer

NCT059851091 siteClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer